1. Home
  2. ONL vs FATE Comparison

ONL vs FATE Comparison

Compare ONL & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Orion Office REIT Inc.

ONL

Orion Office REIT Inc.

HOLD

Current Price

$2.26

Market Cap

111.5M

Sector

Real Estate

ML Signal

HOLD

Logo Fate Therapeutics Inc.

FATE

Fate Therapeutics Inc.

HOLD

Current Price

$1.01

Market Cap

121.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ONL
FATE
Founded
2021
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
111.5M
121.1M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
ONL
FATE
Price
$2.26
$1.01
Analyst Decision
Hold
Buy
Analyst Count
1
7
Target Price
N/A
$3.92
AVG Volume (30 Days)
308.1K
1.4M
Earning Date
11-06-2025
11-13-2025
Dividend Yield
3.59%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$149,775,000.00
$7,137,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.46
$0.66
52 Week High
$4.25
$1.99

Technical Indicators

Market Signals
Indicator
ONL
FATE
Relative Strength Index (RSI) 55.79 42.09
Support Level $1.97 $0.95
Resistance Level $2.28 $1.12
Average True Range (ATR) 0.10 0.07
MACD 0.04 -0.00
Stochastic Oscillator 93.06 24.69

Price Performance

Historical Comparison
ONL
FATE

About ONL Orion Office REIT Inc.

Orion Properties Inc is a internally-managed REIT engaged in the ownership, acquisition, and management of a diversified portfolio of mission-critical and headquarters office buildings located in high quality suburban markets across the U.S. and leased on a single-tenant net lease basis to creditworthy clients. The portfolio of the company includes traditional office buildings, governmental offices, medical offices, laboratories, and others. The Company operates in one business segment: direct ownership and operation of commercial real estate.

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

Share on Social Networks: